{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T12:59:06Z","timestamp":1762865946076},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,2,16]],"date-time":"2012-02-16T00:00:00Z","timestamp":1329350400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1186\/1471-2334-12-42","type":"journal-article","created":{"date-parts":[[2012,2,16]],"date-time":"2012-02-16T11:15:03Z","timestamp":1329390903000},"source":"Crossref","is-referenced-by-count":5,"title":["Comparative activity of carbapenem testing (the COMPACT study) in Turkey"],"prefix":"10.1186","volume":"12","author":[{"name":"Turkish COMPACT Study Group","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hakan","family":"Leblebicioglu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nedim","family":"Cakir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mustafa","family":"Celen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Halil","family":"Kurt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hakan","family":"Baris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joerg","family":"Laeuffer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,2,16]]},"reference":[{"key":"1728_CR1","unstructured":"Health Protection Agency: Surveillance of healthcare associated infections report. [ http:\/\/www.hpa.org.uk\/web\/HPAwebFile\/HPAweb_C\/1216193833496 ]"},{"key":"1728_CR2","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.diagmicrobio.2008.11.004","volume":"63","author":"PJ Turner","year":"2009","unstructured":"Turner PJ: MYSTIC Europe 2007: activity of meropenem and other broad-spectrum agents against nosocomial isolates. Diagn Microbiol Infect Dis. 2009, 63: 217-222. 10.1016\/j.diagmicrobio.2008.11.004.","journal-title":"Diagn Microbiol Infect Dis"},{"key":"1728_CR3","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1099\/jmm.0.2008\/002469-0","volume":"57","author":"D Gur","year":"2008","unstructured":"Gur D, Korten V, Unal S, Deshpande LM, Castanheira M: Increasing carbapenem resistance due to the clonal dissemination of oxacillinase (OXA-23 and OXA-58)-producing Acinetobacter baumannii: report from the Turkish SENTRY Program sites. J Med Microbiol. 2008, 57: 1529-1532. 10.1099\/jmm.0.2008\/002469-0.","journal-title":"J Med Microbiol"},{"key":"1728_CR4","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1093\/jac\/dkh298","volume":"54","author":"RN Jones","year":"2004","unstructured":"Jones RN, Huynh HK, Biedenbach DJ, Fritsche TR, Sader HS: Doripenem (S-4661), a novel carbapenem: comparative activity against contemporary pathogens including bactericidal action and preliminary in vitro methods evaluations. J Antimicrob Chemother. 2004, 54: 144-154. 10.1093\/jac\/dkh298.","journal-title":"J Antimicrob Chemother"},{"key":"1728_CR5","unstructured":"Doribax: Annex I. Summary of product characteristics. European Medicines Agency. [ http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/EPAR_-_Product_Information\/human\/000891\/WC500037148.pdf ]"},{"key":"1728_CR6","unstructured":"Doribax [package insert]. 2009, Ortho-McNeil: Raritan, NJ"},{"key":"1728_CR7","volume-title":"Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically","author":"Clinical and Laboratory Standards Institute","year":"2009","unstructured":"Clinical and Laboratory Standards Institute: Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically. 2009, Wayne, PA, 8","edition":"8"},{"key":"1728_CR8","volume-title":"Performance Standards for Antimicrobial Susceptibility Testing; Twentieth Informational Supplement (June 2010 Update)","author":"Clinical and Laboratory Standards Institute","year":"2010","unstructured":"Clinical and Laboratory Standards Institute: Performance Standards for Antimicrobial Susceptibility Testing; Twentieth Informational Supplement (June 2010 Update). 2010, Wayne, PA"},{"key":"1728_CR9","volume-title":"Performance Standards for Antimicrobial Susceptibility Testing","author":"Clinical and Laboratory Standards Institute","year":"2009","unstructured":"Clinical and Laboratory Standards Institute: Performance Standards for Antimicrobial Susceptibility Testing. 2009, Wayne, PA, 19","edition":"19"},{"key":"1728_CR10","unstructured":"European Committee on Antimicrobial Susceptibility Testing: Breakpoint tables for interpretation of MICs and zone diameters. Version 1.2. [ http:\/\/www.eucast.org\/ ]"},{"key":"1728_CR11","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1093\/jac\/dkr056","volume":"66","author":"P Nordmann","year":"2011","unstructured":"Nordmann P, Picazo JJ, Mutters R, Korten V, Quintana A, Laeuffer JM, Seak JC, Flamm RK, Morrissey I, The COMPACT study group: The Comparative Activity of Carbapenem Testing (COMPACT) study. J Antimicrob Chemother. 2011, 66: 1070-1078. 10.1093\/jac\/dkr056.","journal-title":"J Antimicrob Chemother"},{"key":"1728_CR12","doi-asserted-by":"crossref","first-page":"339","DOI":"10.7883\/yoken.JJID.2008.339","volume":"61","author":"I Erdem","year":"2008","unstructured":"Erdem I, Ozgultekin A, Inan AS, Dincer E, Turan G, Ceran N, Engin DO, Akcay SS, Akgun N, Goktas P: Incidence, etiology, and antibiotic resistance patterns of Gram-negative microorganisms isolated from patients with ventilator-associated pneumonia in a medical-surgical intensive care unit of a teaching hospital in Istanbul, Turkey (2004-2006). Jpn J Infect Dis. 2008, 61: 339-342.","journal-title":"Jpn J Infect Dis"},{"key":"1728_CR13","doi-asserted-by":"crossref","first-page":"228","DOI":"10.7883\/yoken.JJID.2005.228","volume":"58","author":"E Kucukates","year":"2005","unstructured":"Kucukates E: Antimicrobial resistance among Gram-negative bacteria isolated from intensive care units in a cardiology institute in Istanbul, Turkey. Jpn J Infect Dis. 2005, 58: 228-231.","journal-title":"Jpn J Infect Dis"},{"issue":"suppl 2","key":"1728_CR14","first-page":"ii41","volume":"62","author":"DM Livermore","year":"2008","unstructured":"Livermore DM, Hope R, Brick G, Lillie M, Reynolds R, The BSAC Working Parties on Resistance Surveillance: Non-susceptibility trends among Enterobacteriaceae from bacteraemias in the UK and Ireland, 2001-06. J Antimicrob Chemother. 2008, 62 (suppl 2): ii41-ii54.","journal-title":"J Antimicrob Chemother"},{"key":"1728_CR15","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.diagmicrobio.2007.06.016","volume":"59","author":"V Korten","year":"2007","unstructured":"Korten V, Ulusoy S, Zarakolu P, Mete B, Turkish MYSTIC Study Group: Antibiotic resistance surveillance over a 4-year period (2000-2003) in Turkey: results of the MYSTIC Program. Diagn Microbiol Infect Dis. 2007, 59: 453-457. 10.1016\/j.diagmicrobio.2007.06.016.","journal-title":"Diagn Microbiol Infect Dis"},{"key":"1728_CR16","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/j.ijantimicag.2010.08.002","volume":"36","author":"KJ Christiansen","year":"2010","unstructured":"Christiansen KJ, Ip M, Ker HB, Mendoza M, Hsu L, Kiratisin P, Chongthaleong A, Redjeki IS, Quintana A, Flamm R, Garcia J, Cassettari M, Cooper D, Okolo P, Morrissey I: In vitro activity of doripenem and other carbapenems against contemporary Gram-negative pathogens isolated from hospitalised patients in the Asia-Pacific region: results of the COMPACT Asia-Pacific Study. Int J Antimicrob Agents. 2010, 36: 501-506. 10.1016\/j.ijantimicag.2010.08.002.","journal-title":"Int J Antimicrob Agents"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2334-12-42\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-12-42.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-12-42","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-12-42.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,19]],"date-time":"2024-04-19T21:14:31Z","timestamp":1713561271000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/1471-2334-12-42"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2,16]]},"references-count":16,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["1728"],"URL":"https:\/\/doi.org\/10.1186\/1471-2334-12-42","relation":{},"ISSN":["1471-2334"],"issn-type":[{"type":"electronic","value":"1471-2334"}],"subject":[],"published":{"date-parts":[[2012,2,16]]},"article-number":"42"}}